secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001493152-23-027642
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem raises $650K net via $1M convertible note offering and debt-for-preferred exchange
--------------------------------------------------------------------------------

- Issued $1M in senior subordinated convertible notes at 8% interest, convertible at $1.25/share; net proceeds ~$650K.
- Warrants to purchase 799,999 shares at $1.25/share, with price adjustment clauses; expire in 5 years.
- Exchanged $1.8M in existing senior secured notes for 1,800 shares of Series E-1 preferred stock, convertible at $0.40/share.
- Annual meeting scheduled for Sept 14, 2023; proposals include director election, exec comp vote, and share increase to 1.2B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223027642/0001493152-23-027642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223027642/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-027642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer